
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. (TVRD)
WebsitePrice
Market cap
Next catalystEarly Q1 2027TTI-101 — REVERT LIVER CANCER · Phase 1/2 dataSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Background, answer, next evidence
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved